These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 31330185)

  • 1. Autoimmunity, checkpoint inhibitor therapy and immune-related adverse events: A review.
    Khan S; Gerber DE
    Semin Cancer Biol; 2020 Aug; 64():93-101. PubMed ID: 31330185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-related adverse events of checkpoint inhibitors: Insights into immunological dysregulation.
    Yang H; Yao Z; Zhou X; Zhang W; Zhang X; Zhang F
    Clin Immunol; 2020 Apr; 213():108377. PubMed ID: 32135278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The pathology of adverse events with immune checkpoint inhibitors].
    Koelzer VH; Glatz K; Bubendorf L; Weber A; Gaspert A; Cathomas G; Lugli A; Zippelius A; Kempf W; Mertz KD
    Pathologe; 2017 May; 38(3):197-208. PubMed ID: 28421272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers for immune-related toxicities of checkpoint inhibitors: current progress and the road ahead.
    Patil PD; Burotto M; Velcheti V
    Expert Rev Mol Diagn; 2018 Mar; 18(3):297-305. PubMed ID: 29430978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
    Kumar P; Saini S; Prabhakar BS
    Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoimmunity in immune checkpoint inhibitor-induced immune-related adverse events: A focus on autoimmune skin toxicity and pneumonitis.
    Berner F; Flatz L
    Immunol Rev; 2023 Sep; 318(1):37-50. PubMed ID: 37548043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balancing cancer immunotherapy and immune-related adverse events: The emerging role of regulatory T cells.
    Alissafi T; Hatzioannou A; Legaki AI; Varveri A; Verginis P
    J Autoimmun; 2019 Nov; 104():102310. PubMed ID: 31421963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Balancing Act between Cancer Immunity and Autoimmunity in Response to Immunotherapy.
    Young A; Quandt Z; Bluestone JA
    Cancer Immunol Res; 2018 Dec; 6(12):1445-1452. PubMed ID: 30510057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors.
    Dougan M; Blidner AG; Choi J; Cooksley T; Glezerman I; Ginex P; Girotra M; Gupta D; Johnson D; Shannon VR; Suarez-Almazor M; Anderson R; Rapoport BL
    Support Care Cancer; 2020 Dec; 28(12):6129-6143. PubMed ID: 32856210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding adverse events of immunotherapy: A mechanistic perspective.
    Burke KP; Grebinoski S; Sharpe AH; Vignali DAA
    J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of immune-related adverse events: pulmonary toxicity.
    Shannon VR; Anderson R; Blidner A; Choi J; Cooksley T; Dougan M; Glezerman I; Ginex P; Girotra M; Gupta D; Johnson DB; Suarez-Almazor ME; Rapoport BL
    Support Care Cancer; 2020 Dec; 28(12):6145-6157. PubMed ID: 32880733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haematological immune-related adverse events with immune checkpoint inhibitors, how to manage?
    Michot JM; Lazarovici J; Tieu A; Champiat S; Voisin AL; Ebbo M; Godeau B; Michel M; Ribrag V; Lambotte O
    Eur J Cancer; 2019 Nov; 122():72-90. PubMed ID: 31634647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The determinants of very severe immune-related adverse events associated with immune checkpoint inhibitors: A prospective study of the French REISAMIC registry.
    Ruste V; Goldschmidt V; Laparra A; Messayke S; Danlos FX; Romano-Martin P; Champiat S; Voisin AL; Baldini C; Massard C; Laghouati S; Marabelle A; Lambotte O; Michot JM
    Eur J Cancer; 2021 Nov; 158():217-224. PubMed ID: 34627664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of immune-related adverse events during the treatment of cancer with immune checkpoint inhibitors.
    Weinmann SC; Pisetsky DS
    Rheumatology (Oxford); 2019 Dec; 58(Suppl 7):vii59-vii67. PubMed ID: 31816080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanistic classification of immune checkpoint inhibitor toxicity as a pointer to minimal treatment strategies to further improve survival.
    McGonagle D; Bragazzi NL; Amital H; Watad A
    Autoimmun Rev; 2020 Feb; 19(2):102456. PubMed ID: 31838166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.
    Puzanov I; Diab A; Abdallah K; Bingham CO; Brogdon C; Dadu R; Hamad L; Kim S; Lacouture ME; LeBoeuf NR; Lenihan D; Onofrei C; Shannon V; Sharma R; Silk AW; Skondra D; Suarez-Almazor ME; Wang Y; Wiley K; Kaufman HL; Ernstoff MS;
    J Immunother Cancer; 2017 Nov; 5(1):95. PubMed ID: 29162153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational Biomarkers for Checkpoint Inhibitor Immune-Related Adverse Event Prediction and Diagnosis.
    von Itzstein MS; Khan S; Gerber DE
    Clin Chem; 2020 Jun; 66(6):779-793. PubMed ID: 32363387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing Immune-Related Adverse Events in Cancer Immunotherapy.
    Farmer JR
    Clin Lab Med; 2019 Dec; 39(4):669-683. PubMed ID: 31668277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac Immune-Related Adverse Events in Immune Checkpoint Inhibition Therapy.
    Brumbaugh AD; Narurkar R; Parikh K; Fanucchi M; Frishman WH
    Cardiol Rev; 2019; 27(2):97-107. PubMed ID: 29912044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adverse events induced by immune checkpoint inhibitors.
    Perdigoto AL; Kluger H; Herold KC
    Curr Opin Immunol; 2021 Apr; 69():29-38. PubMed ID: 33640598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.